Q3 2018 Virtual Emerging Medtech Spotlight

Conformal and targeted radiation therapy for solid tumors

Collagen-based implants for the treatment of tendon and ligament injuries.

Greenlight Guru is the only quality management platform designed specifically for medical devices companies. The platform helps companies get safer products to market faster, simplifies FDA and ISO regulatory compliance and provides a single source of truth by connecting the management of all quality processes like CAPAs, risk, audits and more. Greenlight Guru's platform is used by thousands of users across the globe to push beyond baseline compliance achieving True Quality.

We are seeking safe and efficient solutions that deliver minimally invasive treatment in the following fields:

-Flexible endoscopic procedures in the Gastrointestinal & Respiratory fields
-Laparoscopic surgery & Gynecological surgery in the General Surgery field
-Flexible or rigid endoscopic procedures in the Urology & Gynecology fields
-Flexible endoscopic procedures in the Ear, Nose and Throat field

Please contact us: medtech_innovation@Olympus.com
(Note) Any ideas, documents or information submitted in contacting us should be on a non-confidential basis. All ideas must have a patent filing.

Office-based modular MRI and MRI based technologies

Novel soft tissue defect closure solution

Ulbrich provides solutions for the most challenging design and manufacturing specifications. Our extensive metallurgical staff and medical product managers are available to assist you in providing various stainless, nitinol, niobium, nickel, titanium and cobalt alloys in the form of precision rolled strip, foil, round, flat and shaped wire for all your medical device needs.

For more than 30 years Ximedica has provided a unique growth platform enabling organizations to successfully deploy medical technology products into the market. Ximedica was formed in 1985 by two Rhode Island School of Design (RISD) graduates, Aidan Petrie and Stephen Lane. From those earliest days to today, the application of "human-centered" design thinking to the innovation and product creation processes remains central to the company's success. In 2014 SV Life Sciences purchased a majority stake in the firm, recognizing that Ximedica is unique in providing a comprehensive service platform - a much needed option in the evolving ecosystem of outsourced medical device development. Throughout its history Ximedica has unearthed new opportunities for clients, solved difficult development challenges, delivered cutting edge innovative solutions and added considerably to patent counts. www.ximedica.com